On 2025-08-13, Aardvark Therapeutics, Inc. (AARD) announced earnings per share of $-0.66 for the fiscal quarter ending 2025-06-30, missing the average analyst estimate of $-0.52.

The next expected annoucement date for quarterly earnings is 2025-11-12, with an average estimated earnings per share of $-0.75 for the fiscal quarter ending 2025-09-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.